Excerpt:

Velcura Therapeutics, Inc.

Founders: Dr. Michael Long, scientific founder, and Mary Ann Alger

CEO: Dr. Michael W. Long

Year established: 2001

Funding to date: Winner of the Great Lakes Venture Quest business plan competition for $60,000; received approval for $3.3 million in funding from the State of Michigan

Number of employees: 7

2002 estimated annual revenue: N/A

Company overview: Velcura Therapeutics is a biotechnology company developing new and better therapies that stimulate bone formation for diseases such as osteoporosis, bone cancer, fractures and other bone diseases. Building on its scientific founder’s patented technology and ability to rapidly isolate and analyze human bone cells, Velcura can grow human bone outside the body (ex vivo) using a rapid (7-10 days), reliable method.